ITCHING INHIBITOR AND ITCHING-INHIBITING COMPOSITION

ITCHING INHIBITOR AND ITCHING-INHIBITING COMPOSITION

PROBLEM TO BE SOLVED: To provide a highly safe itching inhibitor having excellent effects on intractable pruritus cutaneous, and rapidly exhibiting the effects, and to provide an itching-inhibiting composition containing the itching inhibitor as an active ingredient. SOLUTION: The itching inhibitor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KOIZUMI SOJI, TANAKA YOSHIMASA, UOZUMI TAKUYA, MORISHITA SATOSHI
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KOIZUMI SOJI
TANAKA YOSHIMASA
UOZUMI TAKUYA
MORISHITA SATOSHI
description PROBLEM TO BE SOLVED: To provide a highly safe itching inhibitor having excellent effects on intractable pruritus cutaneous, and rapidly exhibiting the effects, and to provide an itching-inhibiting composition containing the itching inhibitor as an active ingredient. SOLUTION: The itching inhibitor contains at least one kind of components (D) selected from a lacto-oligosaccharide (A), an antipruritic (B) and an antiinflammatory agent (C) as essential active ingredients. At least one kind selected from lacto-N-neotetraose and lacto-N-tetraose is used as the lacto-oligosaccharide (A). At least one kind selected from diphenhydramine, crotamiton, derivatives thereof and salts thereof is used as the antipruritic (B). At least one kind selected from dexamethasone, prednisolone, clobetasone butyrate, glycyrrhizinic acid, glycyrrhetinic acid, derivatives thereof and salts thereof is used as the antiinflammatory agent (C). COPYRIGHT: (C)2009,JPO&INPIT
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2009161462A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2009161462A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2009161462A3</originalsourceid><addsrcrecordid>eNrjZDDxDHH28PRzV_D08_B08gzxD1Jw9HNRgIrqQkVBCpz9fQP8g4Fsfz8eBta0xJziVF4ozc2g5OYK1KGbWpAfn1pckJicmpdaEu8VYGRgYGloZmhiZuRoTJQiACJFJ_o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ITCHING INHIBITOR AND ITCHING-INHIBITING COMPOSITION</title><source>esp@cenet</source><creator>KOIZUMI SOJI ; TANAKA YOSHIMASA ; UOZUMI TAKUYA ; MORISHITA SATOSHI</creator><creatorcontrib>KOIZUMI SOJI ; TANAKA YOSHIMASA ; UOZUMI TAKUYA ; MORISHITA SATOSHI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a highly safe itching inhibitor having excellent effects on intractable pruritus cutaneous, and rapidly exhibiting the effects, and to provide an itching-inhibiting composition containing the itching inhibitor as an active ingredient. SOLUTION: The itching inhibitor contains at least one kind of components (D) selected from a lacto-oligosaccharide (A), an antipruritic (B) and an antiinflammatory agent (C) as essential active ingredients. At least one kind selected from lacto-N-neotetraose and lacto-N-tetraose is used as the lacto-oligosaccharide (A). At least one kind selected from diphenhydramine, crotamiton, derivatives thereof and salts thereof is used as the antipruritic (B). At least one kind selected from dexamethasone, prednisolone, clobetasone butyrate, glycyrrhizinic acid, glycyrrhetinic acid, derivatives thereof and salts thereof is used as the antiinflammatory agent (C). COPYRIGHT: (C)2009,JPO&amp;INPIT</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090723&amp;DB=EPODOC&amp;CC=JP&amp;NR=2009161462A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090723&amp;DB=EPODOC&amp;CC=JP&amp;NR=2009161462A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KOIZUMI SOJI</creatorcontrib><creatorcontrib>TANAKA YOSHIMASA</creatorcontrib><creatorcontrib>UOZUMI TAKUYA</creatorcontrib><creatorcontrib>MORISHITA SATOSHI</creatorcontrib><title>ITCHING INHIBITOR AND ITCHING-INHIBITING COMPOSITION</title><description>PROBLEM TO BE SOLVED: To provide a highly safe itching inhibitor having excellent effects on intractable pruritus cutaneous, and rapidly exhibiting the effects, and to provide an itching-inhibiting composition containing the itching inhibitor as an active ingredient. SOLUTION: The itching inhibitor contains at least one kind of components (D) selected from a lacto-oligosaccharide (A), an antipruritic (B) and an antiinflammatory agent (C) as essential active ingredients. At least one kind selected from lacto-N-neotetraose and lacto-N-tetraose is used as the lacto-oligosaccharide (A). At least one kind selected from diphenhydramine, crotamiton, derivatives thereof and salts thereof is used as the antipruritic (B). At least one kind selected from dexamethasone, prednisolone, clobetasone butyrate, glycyrrhizinic acid, glycyrrhetinic acid, derivatives thereof and salts thereof is used as the antiinflammatory agent (C). COPYRIGHT: (C)2009,JPO&amp;INPIT</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDxDHH28PRzV_D08_B08gzxD1Jw9HNRgIrqQkVBCpz9fQP8g4Fsfz8eBta0xJziVF4ozc2g5OYK1KGbWpAfn1pckJicmpdaEu8VYGRgYGloZmhiZuRoTJQiACJFJ_o</recordid><startdate>20090723</startdate><enddate>20090723</enddate><creator>KOIZUMI SOJI</creator><creator>TANAKA YOSHIMASA</creator><creator>UOZUMI TAKUYA</creator><creator>MORISHITA SATOSHI</creator><scope>EVB</scope></search><sort><creationdate>20090723</creationdate><title>ITCHING INHIBITOR AND ITCHING-INHIBITING COMPOSITION</title><author>KOIZUMI SOJI ; TANAKA YOSHIMASA ; UOZUMI TAKUYA ; MORISHITA SATOSHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2009161462A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KOIZUMI SOJI</creatorcontrib><creatorcontrib>TANAKA YOSHIMASA</creatorcontrib><creatorcontrib>UOZUMI TAKUYA</creatorcontrib><creatorcontrib>MORISHITA SATOSHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KOIZUMI SOJI</au><au>TANAKA YOSHIMASA</au><au>UOZUMI TAKUYA</au><au>MORISHITA SATOSHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ITCHING INHIBITOR AND ITCHING-INHIBITING COMPOSITION</title><date>2009-07-23</date><risdate>2009</risdate><abstract>PROBLEM TO BE SOLVED: To provide a highly safe itching inhibitor having excellent effects on intractable pruritus cutaneous, and rapidly exhibiting the effects, and to provide an itching-inhibiting composition containing the itching inhibitor as an active ingredient. SOLUTION: The itching inhibitor contains at least one kind of components (D) selected from a lacto-oligosaccharide (A), an antipruritic (B) and an antiinflammatory agent (C) as essential active ingredients. At least one kind selected from lacto-N-neotetraose and lacto-N-tetraose is used as the lacto-oligosaccharide (A). At least one kind selected from diphenhydramine, crotamiton, derivatives thereof and salts thereof is used as the antipruritic (B). At least one kind selected from dexamethasone, prednisolone, clobetasone butyrate, glycyrrhizinic acid, glycyrrhetinic acid, derivatives thereof and salts thereof is used as the antiinflammatory agent (C). COPYRIGHT: (C)2009,JPO&amp;INPIT</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2009161462A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ITCHING INHIBITOR AND ITCHING-INHIBITING COMPOSITION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A43%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KOIZUMI%20SOJI&rft.date=2009-07-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2009161462A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true